Patent ID: 8921386
Filing Date: 2014-12-30
Classification: A61K,C07D

Abstract:
1. A drug substance selected from the group consisting of: amorphous oxycodone pamoate characterized by at least one method selected from the group consisting of: polymorphic oxycodone pamoate characterized by at least one method selected from the group consisting of: oxycodone xinafoate characterized by at least one method selected from the group consisting of: amorphous morphine pamoate with less than 3 waters of hydration characterized by at least one method selected from the group consisting of: polymorphic morphine pamoate characterized by at least one method selected from the group consisting of: morphine xinafoate characterized by at least one method selected from the group consisting of: hydrocodone xinafoate characterized by at least one method selected from the group consisting of: amorphous hydromorphone pamoate characterized by at least one method selected from the group consisting of: polymorphic hydromorphone pamoate characterized by at least one method selected from the group consisting of: hydromorphone xinafoate characterized by at least one method selected from the group consisting of: